Filtros de búsqueda

Lista de obras de L Biordi

CXCR4 pharmacogical inhibition reduces bone and soft tissue metastatic burden by affecting tumor growth and tumorigenic potential in prostate cancer preclinical models.

artículo científico publicado en 2015

Chemokine MIP-2/CXCL2, acting on CXCR2, induces motor neuron death in primary cultures

scientific journal article

Determination of famotidine in plasma, urine and gastric juice by high-performance liquid chromatography using disposable solid-phase extraction columns

artículo científico publicado en 1988

Determination of imipenem in human plasma, urine and tissue by high-performance liquid chromatography

scientific article published on 01 January 1990

Differential expression of the components of the plasminogen activating system in human thyroid tumour derived cell lines and papillary carcinomas.

artículo científico publicado en 2006

Effects of EGFR tyrosine kinase inhibitor erlotinib in prostate cancer cells in vitro.

artículo científico publicado en 2009

Inhibition of interleukin-8 (CXCL8/IL-8) responses by repertaxin, a new inhibitor of the chemokine receptors CXCR1 and CXCR2

artículo científico publicado en 2005

Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.

artículo científico publicado en 2005

New mutations and protein variants of NBS1 are identified in cancer cell lines

scientific article published on 01 February 2003

Ontogenesis and cell specific localization of Fas ligand expression in the rat testis.

artículo científico publicado en 2004

Simultaneous determination of simvastatin and its hydroxy acid form in human plasma by high-performance liquid chromatography with UV detection

scientific article published on 01 September 1992

The TORC1/TORC2 inhibitor, Palomid 529, reduces tumor growth and sensitizes to docetaxel and cisplatin in aggressive and hormone-refractory prostate cancer cells.

artículo científico publicado en 2011

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda